-
Migalastat, sold
under the
brand name Galafold, is a
medication for the
treatment of
Fabry disease, a rare
genetic disorder. It was
developed by Amicus...
- multi-year
collaboration agreement with
Shire for its lead compound,
migalastat, and two
other products.: 24
Amicus cut 20% of its workforce.: 24 The...
- on
pharmacological chaperone therapy is
available for
Fabry disease:
Migalastat, sold
under the
brand name
Galafold by the
company Amicus Therapeutics...
- iminosugar. 1-deoxynojirimycin or
duvoglustat 1-deoxygalactonojirimycin or
migalastat, a drug for the
treatment of
Fabry disease Inouye, S.; Tsuruoka, T.; Ito...
- globotriaosylceramide,
causing Fabry's disease. The
pharmaceutical drug
migalastat enhances the
function of alpha-galactosidase and is used to
treat Fabry's...
- 0845 u) may
refer to:
Bicine 1-Deoxynojirimycin, or
moranolin Perosamine Migalastat This set
index page
lists chemical structure articles ****ociated with...
- Enzymedica's Bean****ist
Gasfix Bloa**** (in
India as Cogentrix) β-galactosidase
Migalastat, a drug
targeting α-galactosidase
classification of α-galactosidases (according...
- The
company has a
Pompe treatment in development, as well as
Galafold (
migalastat),
which is for
Fabry disease. The company's
Fabry drug was
approved for...
-
treatments include diabetes,
inherited cataracts and
cystic fibrosis.
Migalastat is a
pharmacological chaperone for the
treatment of
Fabry disease. Tafamidis...
-
Sodium benzoate A16AX12
Trientine A16AX13
Uridine triacetate A16AX14
Migalastat A16AX15
Telotristat A16AX16
Givosiran A16AX17
Triheptanoin A16AX18 Lumasiran...
